A Clinical Update on MASLD

This Clinical Insights discusses new diagnostic criteria, risk stratification, and emerging treatments of metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease).

Authors

Grace Y. Zhang
Danielle Brandman (ORCID: https://orcid.org/0000-0003-3244-4696)

Institutions

University of California, San Francisco (US)
Cornell University (US)

Publication Details

Journal: JAMA Internal Medicine
Published: 2024-11-25
DOI: https://doi.org/10.1001/jamainternmed.2024.6431
Citations: 21
Primary Topic: Liver Disease Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 8.12

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Clinical Update on MASLD

Grace Y. Zhang, Danielle Brandman

Nov 25, 2024

21 citations

JAMA Internal Medicine

Liver Disease Diagnosis and Treatment

8.12

article

A Clinical Update on MASLD

Grace Y. Zhang, Danielle Brandman

November 25, 2024article en

21 citations

Abstract

JAMA Internal MedicineVol. 185(1)

University of California, San Francisco (US), Cornell University (US)

Good health and well-being

Openalex Percentile: Top 2%

Liver Disease Diagnosis and Treatment

8.12

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.